Fund Description
The investment seeks to provide investment results that correspond generally, before fees and expenses, to the price and yield performance of the Bank of New York Europe 100 ADR Index. The fund typically invests substantially all of its assets in the securities that make up the index. It is non-diversified.
Fund Snapshot Updated 06.17.2013
| Previous Close | — | Expense Ratio | 0.30% |
| YTD Return | 5.6% | Avg. 30-Day Volume | 1,607 |
| 1-Year Return | 25.6% | Market Cap | Loading... |
| Bid | $21.99 | Shares Outstanding | 650,000 |
| Ask | $22.07 | Dividends | $0.72 |
| Top 10 Holdings | |
|---|---|
| Hsbc Hldgs Plc (HBC) | 6.05% |
| Novartis A G (NVS) | 6.03% |
| Vodafone Group Plc New (VOD) | 4.27% |
| Bp Plc (BP) | 4.18% |
| Sanofi (SNY) | 4.11% |
| Glaxosmithkline Plc (GSK) | 3.94% |
| Royal Dutch Shell Plc (RDS.A) | 3.75% |
| Total S A (TOT) | 3.67% |
| British Amern Tob Plc (BTI) | 3.28% |
| Royal Dutch Shell Plc (RDS.B) | 2.77% |
| % of Total Holdings | 42.10% |
